Trial
NCT06153420
Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
CinPhloro Pharma, LLC
Collaborators
—
Condition
Irritable Bowel Syndrome With Diarrhea
Intervention
CIN-103
Why stopped
The study was terminated due to lack of efficacy compared to placebo.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-15